As part of our mission, we’re working to address complications of kidney disease. That's why we work to leverage our scientific expertise and innovative thinking to develop clinical advances in areas that are important to those living with CKD.
Auryxia® (ferric citrate)
We currently market Auryxia in the U.S. for two approved indications:
- The control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis
- The treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis